This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Paramount Group (PGRE) Q1 FFO and Revenues Top Estimates
by Zacks Equity Research
Paramount Group (PGRE) delivered FFO and revenue surprises of 9.52% and 0.26%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Paramount Group (PGRE) Tops Q4 FFO and Revenue Estimates
by Zacks Equity Research
Paramount Group (PGRE) delivered FFO and revenue surprises of 4.35% and 4.08%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Paramount Group (PGRE) Lags Q3 FFO Estimates
by Zacks Equity Research
Paramount Group (PGRE) delivered FFO and revenue surprises of -4.35% and 1.06%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Should Value Investors Pick Paramount Group (PGRE) Stock?
by Zacks Equity Research
Let's see if Paramount Group, Inc. (PGRE) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Paramount Group (PGRE) Matches Q2 FFO Estimates
by Zacks Equity Research
Paramount Group (PGRE) delivered FFO and revenue surprises of 0.00% and -4.69%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
PGRE or CUBE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PGRE vs. CUBE: Which Stock Is the Better Value Option?
PGRE or CUBE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PGRE vs. CUBE: Which Stock Is the Better Value Option?
Paramount Group (PGRE) Beats Q3 FFO and Revenue Estimates
by Zacks Equity Research
Paramount Group (PGRE) delivered FFO and revenue surprises of 4.17% and 1.27%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
CBRE Group (CBRE) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Though CBRE Group (CBRE) Q3 results will likely reflect benefits from improving occupier outsourcing business and strategic acquisitions, softer investment volumes are a concern.
What to Expect From Americold (COLD) This Earnings Season?
by Zacks Equity Research
Americold's (COLD) Q3 performance likely to reflect steady demand for its properties, driven by consumption growth, favorable industry trends and productivity-improvement benefits.
Omega Healthcare (OHI) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Though Omega Healthcare (OHI) will likely reflect record top-line growth in Q3, tenant credit headwinds and low Medicaid rates in Texas might have impeded any robust growth.
Key Factors to Impact JLL's Performance This Earnings Season
by Zacks Equity Research
Jones Lang LaSalle's (JLL) Q3 results to reflect strength across its global regions and rising trend of outsourcing of real estate needs, though softer investment volumes remain a concern.
Key Factors to Impact Arbor Realty's (ABR) Q3 Earnings
by Zacks Equity Research
Arbor Realty Trust's (ABR) Q3 performance likely to reflect the stable earnings power of agency business and growth in its loan business amid competitive lending market.
Paramount Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Paramount Group has been struggling lately, but the selling pressure may be coming to an end soon.
Paramount Group (PGRE) Surpasses Q2 FFO Estimates
by Zacks Equity Research
Paramount Group (PGRE) delivered FFO and revenue surprises of 4.55% and -1.52%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Zacks.com featured highlights include: Ready Capital, Gladstone, NeoGenomics, Digi and Paramount
by Zacks Equity Research
Zacks.com featured highlights include: Ready Capital, Gladstone, NeoGenomics, Digi and Paramount
5 Breakout Stocks for Stellar Returns
by Swarup Gupta
This method involves zeroing in on stocks whose prices vary within a narrow band.
Paramount Group (PGRE) Q3 FFO Lag Estimates
by Zacks Equity Research
Paramount Group (PGRE) delivered FFO and revenue surprises of -4.00% and 0.41%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Paramount Group (PGRE) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Paramount Group (PGRE) delivered earnings and revenue surprises of 4.35% and 1.75%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Here's Why You Should Hold MAA Stock in Your Portfolio
by Zacks Equity Research
Mid-America Apartment Communities (MAA) to see more demand and rent in labor market upturn. But geographic concentration exposes it to economic and political doldrums, threatening long-time growth.
Should You Buy Paramount Group (PGRE) Ahead of Earnings?
by Zacks Equity Research
Paramount Group (PGRE) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
RE/MAX Holdings (RMAX) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Although RE/MAX Holdings (RMAX) has a vast agent network, escalating expenses, stemming from investment in Motto Mortgage and technological infrastructure, might put pressure on its Q3 results.
Will E-Retail Impact Federal Realty's (FRT) Q3 Earnings?
by Zacks Equity Research
Federal Realty's (FRT) portfolio-repositioning efforts position it well for better Q3 results. However, mounting pressure from online retailers is expected to prevent it from delivering stellar performance.
Regency Centers (REG) Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Regency Centers' (REG) solid portfolio of grocery anchored shopping centers will likely aid in maintaining mall traffic. Moreover, its merger with Equity One will likely boost Q3 results.
What to Expect from Rayonier (RYN) This Earnings Season?
by Zacks Equity Research
Despite a favorable demand supply dynamics, Rayonier's (RYN) results are expected to be affected by intense competition from a variety of substitute products in Q3.